Cormorant Asset Management, LP Arcellx, Inc. Transaction History
Cormorant Asset Management, LP
- $1.27 Billion
- Q4 2024
A detailed history of Cormorant Asset Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,300,000 shares of ACLX stock, worth $84.2 Million. This represents 7.82% of its overall portfolio holdings.
Number of Shares
1,300,000
Previous 1,250,000
4.0%
Holding current value
$84.2 Million
Previous $104 Million
5.15%
% of portfolio
7.82%
Previous 7.31%
Shares
11 transactions
Others Institutions Holding ACLX
# of Institutions
224Shares Held
45.1MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$283 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$243 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$228 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$225 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$216 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.84B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...